⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL9054771 | 0.94 | — | — | |
| SCHEMBL10706856 | 0.78 | — | — | |
| Sulfuric Acid SCHEMBL1396634 | 0.75 | — | — | |
| Sulfuric Acid SCHEMBL5477467 | 0.75 | — | — | |
| Sulfamate SCHEMBL3076137 | 0.75 | — | — | |
| Sulfuric Acid SCHEMBL27977625 | 0.75 | CA5A (0.75) | — | |
| Sulfuric Acid SCHEMBL8532128 | 0.72 | CA5A (1.00) | — | |
| Sulfuric Acid SCHEMBL418399 | 0.72 | CA5A (1.00) | — | |
| Sulfuric Acid SCHEMBL3699224 | 0.72 | CA5A (1.00) | — | |
| Sulfuric Acid SCHEMBL110268 | 0.72 | CA5A (1.00) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2092 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3512548-B1 | ANTIBODY AND CHECKPOINT INHIBITOR COMBINATION THERAPY | BIONOMICS LTD (AU) | 2023-03-22 | — | — | EP | claimed |
| CN-114934287-A | Method for synthesizing fluoroalkyl-substituted sulfamino polycyclic compound by electrooxidation | 浙江师范大学 | 2022-08-23 | — | — | CN | claimed |
| US-20220022395-A1 | JASMONIC ACID ENDOGENY PROMOTING AGENT, AND METHOD FOR PROMOTING JASMONIC ACID ENDOGENY | TOKYO UNIVERSITY OF SCIENCE FOUNDATION (JP) | 2022-01-27 | — | — | US | claimed |
| EP-3903576-A1 | JASMONIC ACID ENDOGENY PROMOTING AGENT, AND METHOD FOR PROMOTING JASMONIC ACID ENDOGENY | Tokyo University of Science Foundation (JP) | 2021-11-03 | — | — | EP | claimed |
| US-20210138080-A1 | CONJUGATES | GLYKOS BIOMEDICAL OY (FI) | 2021-05-13 | — | — | US | claimed |
| EP-3813883-A1 | CONJUGATES | Glykos Biomedical Oy (FI) | 2021-05-05 | — | — | EP | claimed |
| US-10954231-B2 | Anxiolytic compounds | BIONOMICS LIMITED (AU) | 2021-03-23 | — | — | US | claimed |
| US-20210061800-A1 | COMPOUNDS FOR TREATING EYE DISEASES AND METHODS THEREOF | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2021-03-04 | — | — | US | claimed |
| WO-2020138228-A1 | JASMONIC ACID ENDOGENY PROMOTING AGENT, AND METHOD FOR PROMOTING JASMONIC ACID ENDOGENY | 学校法人東京理科大学 | 2020-07-02 | — | — | WO | claimed |
| US-10564162-B2 | Predictive biomarkers | BIONOMICS LIMITED (AU) | 2020-02-18 | — | — | US | claimed |
| US-4226866-A | BACTERICIDES, ACYLATION | MERCK & CO., INC. (US) | 1980-10-07 | — | — | US | claimed |
| US-4177274-A | ANTHELMINTICS | MERCK & CO., INC. (US) | 1979-12-04 | — | — | US | claimed |
| EP-0003814-A2 | Penicillins, their salts, process for their preparation and pharmaceutical compositions containing them | Dr. Karl Thomae GmbH (DE) | 1979-09-05 | — | — | EP | claimed |
| US-4096264-A | ANTHELMINTICS | MERCK & CO., INC. (US) | 1978-06-20 | — | — | US | claimed |
| US-4066762-A | ANTIBACTERIAL | SMITHKLINE CORPORATION (US) | 1978-01-03 | — | — | US | claimed |
| US-4060687-A | Cephalosporins having a 3-α substituted alkyl grouping | MERCK & CO., INC. (US) | 1977-11-29 | — | — | US | claimed |
| US-4032521-A | ANTIBIOTICS | MERCK & CO., INC. (US) | 1977-06-28 | — | — | US | claimed |
| US-4031229-A | SUBSTITUTED IMIDAZOLIDINONE-PENICILLANIC ACIDS, BACTERICIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1977-06-21 | — | — | US | claimed |
| US-3979384-A | ANTIBIOTICS | MERCK & CO., INC. (US) | 1976-09-07 | — | — | US | claimed |
| US-3931142-A | Heterocyclic containing disazo compounds | CIBA-GEIGY AG (CH) | 1976-01-06 | — | — | US | claimed |